Maureen Canavan, PhD, MPH
Associate Research Scientist (General Medicine)Cards
About
Titles
Associate Research Scientist (General Medicine)
Affiliated Faculty, Yale Institute for Global Health
Biography
Maureen E. Canavan, Ph.D., is an epidemiologist at Yale Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) since 2017. In addition to working the MCBS data, she works as part of the Yale Cancer Center’s Cancer Care Innovations Lab (CaCIL) team evaluating quality metrics for cancer care. Her research interests include health management, employment, and end of life care. Prior to her work at COPPER, she was a member of the Global Health Leadership Institute (GHLI) team, she conducts qualitative and quantitative data analysis of GHLI studies in countries including Ghana, Ethiopia and China. She received an M.P.H. from the University of Medicine and Dentistry of New Jersey, School of Public Health and a B.S. from Pennsylvania State University.
Last Updated on May 21, 2025.
Appointments
General Internal Medicine
Associate Research ScientistPrimary
Other Departments & Organizations
- COPPER Center
- General Internal Medicine
- Internal Medicine
- Obesity Research Working Group
- Yale Institute for Global Health
Education & Training
- PhD
- Yale University Graduate School (2011)
- MPH
- University of Medicine and Dentistry of New Jersey, School of Public Health, Epidemiology, Health Education, and Behavioral Science (2005)
- BS
- Pennsylvania State University, Biology (2003)
Research
Publications
2026
Updated Review: Using the National Cancer Database for Outcomes-Based Research.
Ayoade O, Caturegli G, Palis B, McCabe R, Weigel R, Canavan M, Boughey J, Boffa D. Updated Review: Using the National Cancer Database for Outcomes-Based Research. Journal Of The American College Of Surgeons 2026 PMID: 41848188, DOI: 10.1097/xcs.0000000000001924.Peer-Reviewed Original ResearchNational Cancer DatabaseFollow-upNon-small cell lung cancerAmerican CollegeCell lung cancerNarrative reviewCancer Reporting SystemCancer-accredited hospitalsPD-L1Tumor gradeTumor sizeCancer DatabaseContinuous tumor sizeLung cancerSmoking statusOutcomes-based researchOncology practiceSurvival dataMedicaid expansion statusOutcome studiesFollow-up limitCancerTreatment reportsPolicy changesPolicy-relevant dataUse of Complementary and Alternative Medicine in the Management of Breast Cancer
Ayoade O, Caturegli G, Canavan M, Resio B, Berger E, Boffa D. Use of Complementary and Alternative Medicine in the Management of Breast Cancer. JAMA Network Open 2026, 9: e260337. PMID: 41770560, PMCID: PMC12954545, DOI: 10.1001/jamanetworkopen.2026.0337.Peer-Reviewed Original ResearchConceptsCohort studyManagement of breast cancerBreast cancerCohort study of dataMedical management of breast cancerTreated with CAMCox proportional hazards modelsMedical managementYear of diagnosisFemale patientsCombination of CAMProportional hazards modelTraditional therapiesAlternative medicineStudy of dataMain OutcomesEndocrine therapyNo treatmentCharlson Comorbidity IndexInsurance typeNonmedical personnelPrimary outcomeFacility typeSurvival timeHazards model
2025
Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality
Canavan M, Cheng L, Xiang J, Lin J, Hui D, Zhao H, Nortje N, Ratan R, Cherny N, Pham T, Giordano S, Niu J, Adelson K. Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality. Journal Of Clinical Oncology 2025, 43: 3391-3402. PMID: 41004691, DOI: 10.1200/jco-25-00530.Peer-Reviewed Original ResearchThis study investigates the impact of systemic anticancer therapy near the end of life on healthcare and hospice for older adults, showing increased acute care utilization and decreased hospice use, highlighting the need for improved end-of-life care guidelines.Real-world perioperative outcomes of neoadjuvant chemoimmunotherapy in non–small cell lung cancer
Caturegli G, Kaminski M, Canavan M, Ayoade O, Resio B, Boffa D. Real-world perioperative outcomes of neoadjuvant chemoimmunotherapy in non–small cell lung cancer. JTCVS Open 2025, 28: 554-564. PMID: 41473080, PMCID: PMC12745116, DOI: 10.1016/j.xjon.2025.09.016.Peer-Reviewed Original ResearchNon-small cell lung cancerPathological complete responseNational Cancer DatabaseNeoadjuvant chemoimmunotherapyCell lung cancerChemoimmunotherapy patientsNeoadjuvant chemoradiotherapyPerioperative outcomesStage I to III non-small cell lung cancerIII non-small cell lung cancerLung cancerTreated with neoadjuvant chemoimmunotherapyNon-small cell lung cancer recurrenceOutcome of immunotherapyPeri-operative outcomesMethods Adult patientsInduction chemoimmunotherapyComplete responseNeoadjuvant chemotherapyNodal downstagingPerioperative therapyCancer DatabasePneumonectomy rateChemoimmunotherapyAdult patientsMortality Risk and Cause of Death Associated With Removal of the Adult Thymus: Analysis of the U.S. Thymoma Population
Resio B, Canavan M, Caturegli G, Detterbeck F, Boffa D. Mortality Risk and Cause of Death Associated With Removal of the Adult Thymus: Analysis of the U.S. Thymoma Population. Journal Of Thoracic Oncology 2025, 21: 186-194. PMID: 40865907, DOI: 10.1016/j.jtho.2025.08.017.Peer-Reviewed Original ResearchSurveillance Epidemiology and End ResultsNational Cancer DatabaseDuctal carcinoma in situPropensity-matched patientsThyroid cancerAdult thymusU.S. populationImmunologic end pointsCarcinoma in situFive-year survivalCancer incidencePartial thymectomyThyroid lobectomyResected breastLonger-term outcomesPartial mastectomyThyroid neoplasmsTotal thymectomyCancer DatabaseCause of deathNo significant differenceSecondary cancersSmall thymomaThymectomyEnd ResultsHypertensive Disorders of Pregnancy and Breastfeeding Among US Women
Nardella D, Canavan M, Taylor S, Sharifi M. Hypertensive Disorders of Pregnancy and Breastfeeding Among US Women. JAMA Network Open 2025, 8: e2521902. PMID: 40679825, PMCID: PMC12274979, DOI: 10.1001/jamanetworkopen.2025.21902.Peer-Reviewed Original ResearchConceptsPrevention's Pregnancy Risk Assessment Monitoring SystemAssociated with higher oddsBreastfeeding cessationCross-sectional studyPostpartum womenHypertensive disordersHigher oddsSelf-reported high blood pressurePregnancy Risk Assessment Monitoring SystemCenters for Disease Control and Prevention's Pregnancy Risk Assessment Monitoring SystemBreastfeeding support strategiesFirst-time mothersHypertensive disorders of pregnancyMedian timeHigh blood pressureHealth covariatesDisorders of pregnancyBreastfeeding initiationMother-infant dyadsMain OutcomesBreastfeeding outcomesMedicaid insuranceSupport strategiesBreastfeedingComplete dataPrescribing GLPs for Obesity Treatment for Adults at a University Based Health Maintenance Organization by Race, Ethnicity, and Socioeconomic Status
Chen A, Brunetto W, Canavan M, Lipska K, Richey E, Wilson M, Zarro J, Ross J. Prescribing GLPs for Obesity Treatment for Adults at a University Based Health Maintenance Organization by Race, Ethnicity, and Socioeconomic Status. Journal Of General Internal Medicine 2025, 41: 499-505. PMID: 40588707, PMCID: PMC12894581, DOI: 10.1007/s11606-025-09691-4.Peer-Reviewed Original ResearchHealth maintenance organizationStaff-model health maintenance organizationArea Deprivation IndexBody mass indexLow socioeconomic statusSocioeconomic statusNon-Hispanic patientsPrescription receiptMaintenance organizationBlack patientsPatients of low socioeconomic statusHispanic patientsElectronic health record dataWhite patientsHealth record dataObesity treatmentDesignCross-sectional studyAssociation of raceHighest prevalencePrevalence of prescriptionsSelf-reported raceMain outcome measuresLogistic regression modelsObesity-related conditionsDeprivation indexProlonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis
Zhan P, Canavan M, Bader J, Boffa D, Resio B, Woodard G. Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis. The Annals Of Thoracic Surgery 2025, 121: 633-642. PMID: 40588180, DOI: 10.1016/j.athoracsur.2025.06.015.Peer-Reviewed Original ResearchNational Cancer DatabaseLong-term survivalSurgical resectionOverall survivalPleural mesotheliomaClinical stage I diseaseCurative-intent surgical resectionNational Cancer Database dataNational Cancer Database AnalysisDiagnosis of malignant pleural mesotheliomaDeclined surgical resectionEpithelioid histological typeChemotherapy-treated patientsNonsurgically treated patientsStage I diseaseMalignant pleural mesotheliomaMultivariate logistic regression modelPropensity-matched cohortPropensity score matchingI diseaseSurvival benefitHistological typeSurgery 2Prolonged survivalCancer DatabaseErratum to ‘Recent Survival Gains in Stage IV NSCLC by Sociodemographic Strata’ [JTO Clinical and Research Reports Volume 6 Issue 4 (2025) 100798]
Ayoade O, Canavan M, Zolfaghari E, Caturegli G, Kim S, Boffa D. Erratum to ‘Recent Survival Gains in Stage IV NSCLC by Sociodemographic Strata’ [JTO Clinical and Research Reports Volume 6 Issue 4 (2025) 100798]. JTO Clinical And Research Reports 2025, 6: 100850. PMID: 41473839, PMCID: PMC12745935, DOI: 10.1016/j.jtocrr.2025.100850.Commentaries, Editorials and LettersSalary Differences by Gender, Race, and Ethnicity Among Assistant Professors at US Medical Schools
Owda D, Mensah M, Yang D, Canavan M, Gross C, Chaudhry S. Salary Differences by Gender, Race, and Ethnicity Among Assistant Professors at US Medical Schools. JAMA Network Open 2025, 8: e259583. PMID: 40366659, PMCID: PMC12079292, DOI: 10.1001/jamanetworkopen.2025.9583.Peer-Reviewed Original ResearchConceptsUS medical schoolsCross-sectional studyClinical specialtiesMedical schoolsWhite menMedian annual salaryWhite physiciansEthnic disparitiesMain OutcomesSalary ratioURiMSpecialtySalary inequitiesEthnicityWomenPhysiciansDisparitiesSalary disparitiesMenRaceGenderAnnual salarySalary dataSalary differencesAggregate data
Academic Achievements & Community Involvement
News
News
- January 08, 2026Source: JCO Podcast
Podcast: Association Between EOL SACT and Healthcare Utilization
- October 22, 2025Source: Cure
Improving End-of-Life Care: Making Hospice and Home Support Accessible
- May 28, 2025
United by Cancer Research: One Mission. One Voice
- June 07, 2024
Yale Cancer Center Researchers and Trainees Present at ASCO